The clinical outcome of patients with Stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: A Cooperation Task Force (CTF) study

Purpose of investigation: The objective of this retrospective multicenter study was to assess the clinical outcome of patients with microinvasive squamous cell carcinoma of the uterine cervix.

Methods: The hospital records of 166 patients with microinvasive squamous cell carcinoma of the uterine cervix were reviewed. All cases were retrospectively staged according the 1994 International Federation of Gynecology and Obstetrics (FIGO) nomenclature. One hundred and forty-three cases were in Stage Ia1 and 23 in Stage Ia2 disease. Surgery consisted of conization alone in 30 (18.1%) patients, total hysterectomy in 82 (49.4%), and radical hysterectomy in 54 (32.5%). All patients in whom conization was the definite treatment had Stage Ia1 disease and had cone margins negative for intraepithelial or invasive lesions.

Results: None of the 67 patients submitted to pelvic lymphadenectomy had histologically proven metastatic lymph nodes. Of the 166 patients, eight (4.8%) had an intraepithelial recurrence and four (2.4%) had an invasive recurrence. With regard to FIGO substage, disease recurred in nine (6.3%) out of 143 patients with Stage Ia1 and three (13.0%) out of 23 with Stage Ia2 cervical cancer. With regard to type of surgery, disease recurred in three (10.0%) out of the patients treated with conization alone, four (4.9%) out those who underwent total hysterectomy, and five (9.3%) out of those who underwent radical hysterectomy. It is worth noting that none of the 30 patients treated with conization alone had recurrent invasive cancer after a median follow-up of 45 months. However three (10%) of these patients developed a cervical intraepithelial neoplasia (CIN) III after 16, 33, and 94 months, respectively, from conization.

Conclusions: Conization can represent the definite treatment for patients with Stage Ia1 squamous cell cervical cancer, if cone margins and apex are disease-free. For patients with Stage Ia2 cervical cancer extrafascial hysterectomy with pelvic lymphadenectomy might be an adequate standard therapy, although the need for lymph node dissection is questionable.

Microinvasive cervical cancer; Pelvic lymph nodes; Conization; Childbearing ability; Hysterectomy; Recurren

[1] Seski J.C., Abell M.R., Morley G.W.: "M1cromvas1ve squamous carcinoma of the cervix: Definition, histologic analysis, late results of treatment". Ohstet. Gynecol., 1977, 50, 410.

[2] Benson W.L., Norris H.J.: "A critical review of the frequency of lymph node metastasis and death from microinvasive carcinoma of the cervix". Obstet. Gynecol., 1977, 49, 632.

[3] Japanese Joint Study Committee on Stage Ia cancer in the utenne cervix: "A new proposal regarding criteria for stage Ia cancer in the uterine cervix". Gynecol. Oncol., 1979, 8, 353.

[4] Sedlis A., Sall S., Tsukada Y., Park R., Mangan C., Shingleton H., Blessing J.A.: "Microinvasive carcinoma of the uterine cervix: A clinical-pathologic study". Am. J. Obstet. Gynecol., 1979, 133, 64.

[5] van Nagell J.R. Jr., Greenwell N., Powell D.F., Donaldson E.S., Hanson M.B., Gay E.C.: "Microinvasive carcinoma of the cervix" Am. J. Obstet. Gynecol., 1983, 145, 981.

[6] Creasman W.T., Fetter B.F., Clarke-Pearson D.L., Kaufmann L., Parker R.T.: "Management of Stage IA carcinoma of the cervix". Am. J. Obstet. Gynecol., 1985, 153, 164.

[7] Tsukamoto N., Kaku T., Matsukuma K., Matsuyama T., Kamura T., Saito T., Suenaga T.:'The problem of stage la (FIGO, 1985) carcinoma of the uterine cervix". Gynecol. Oneal., 1989, 34, 1.

[8] Kolstad P.: "Follow-up study of 232 patients with Stage Ia, and 411 patients with Stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma)". Gynecol. Oneal., 1989, 33, 265.

[9] Burghardt E., Girardi F., Lahousen M., Pickel H., Tamussino K.： "Microinvasive carcinoma of the uterine cervix (International F ederation of Gynecology and Obstetrics Stage IA)". Cancer, 1991, 67, 1037.

[10] Copeland L.J., Silva E.G., Gershenson D.M., Morris M., Young D.C., W harton J.T.: "Superficially invasive squamous cell carcinona of the cervix". Gynecol. Oneal., 1992, 45, 307.

[11] Sevin B.U., Nadji M., Averette H.E., Hilsenbeck S., Smith D., Lampe B.: "Microinvasive carcinoma of the cervix". Cancer, 1992, 70, 2121.

[12] Ostor A.G.: "Studies on 200 cases of early squamous cell carcinoma of the cervix". Int. J. Gynecol. Pathol., 1993, 12, 193.

[13] Benedet J.L., Anderson G.H.: "Stage IA carcinoma of the cervix revisited". Obstet. Gynecol., 1996, 87, 1052.

[14] Creasman W.T., Zaino R.J., Major F.J., DiSaia P.J., Hatch K.D., Homesley H.D.: "Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study". Am. J. Obstet. Gynecol., 1998, 178, 62.

[15] Creasman W.T.: "Stage IA cancer of the cervix: Finally some resolution of definition and treatment?". Gynecol. Oneal., 1999, 74, 163.

[16] Rakar S.: "The place of radical hysterectomy in the treatment of early cervical cancer". In: "ESGOI 2002. New technologies for Gynecologic and Obstetric Investigation". Genazzani A.R., Cela V., Artini P.G. (eds.), Rome, CIC Edizioni lntemazionali, 2002, 298.

[17] Nam J.H., Kim S.H., Kim J.H., Kim Y.M., Kim Y.T., Mok J.E.: "Nonradical treatment is as effective as radical surgery in the management of cervical cancer Stage IA,". Int. J. Gynecol. Cancer, 2002, 12, 480.

[18] Staging announcement: "F IGO Cancer Committee". Gynecol. Oneal., 1986, 25, 383.

[19] Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., Heintz A.P.M. et al.: "Carcinoma of the cervix uteri''. J. Epi demiol. Biostat., 2001, 6, 5.

[20] Webb J.C., Key C.R., Qualls C.R., Smith H.O.: "Population-based study of microinvasive adenocarcinoma of the uterine cervix". Ohstet. Gynecol., 2001, 97, 701.

[21] Morris M., Mitchell M.F., Silva E.G., Copeland L.J., Gershenson D.M.: "Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix". Gynecol. Oneal., 1993, 51, 193.

[22] Winter R.: "Conservative surgery for microinvasive carcinoma of the cervix". J. Ohstet. Gynaecol. Res., 1998, 24, 433.

[23] Andersen E.S., Nielsen K., Pedersen B.: "Combination laser conization as treatment of microinvasive carcinoma of the uterine cervix". Eur. J. Gynaecol. Oneal., 1998, 19, 352

[24] Rakar S., Eren M.: "Conservative surgical management of early stage cervical cancer". In: "Proceedings of the IO'h World Congress of Cervical Pathology and Colposcopy". Testa R., Jakob C.A., Huguet J.O. (eds.),B uenos Aires,M onduzzi Editore,1999, 31.

[25] Dargent D., Martin X., Sacchetoni A., Mathevet P.: "Laparoscopic vaginal radical trachelectomy: A treatment to preserve the fertility of cervical carcinoma patients". Cancer, 2000, 88, 1877.

[26] Plante M., Roy M.: "New approaches in the surgical management of early cervical cancer". Curr. Opin. Ohstet. Gynecol., 2001, 13, 41.

[27] Lecuru F., Neji K., Robin F., Vilde F., Taurelle R.: "Microinvasive carcinoma uterine cervix. W hich approach in 1998?". Bull. Cancer, 1998, 85, 319.

[28] Lecuru F., Hoffman H., Mezan de Malartic C., Taurelle R.: "Microinvasive cervical cancer". J. Gynecol. Ohstet. Biol Reprod., 1997, 26, 662.

[29J Okamoto Y., Ueki K., Ueki M.: "Pathological indications for conservative therapy in treating cervical cancer". Acta Obst et. Gynecol. Scand., 1999, 78, 818.

[30] Bekkers R.L., Keyser K.G., Bulten J., Hanselaar A.G., Schijf C.P., Boonstra H., Massuger L.F.: "The value of loop electrosurgical conization in the treatment of stage IA 1 microinvasive carcinoma of the uterine cervix". Int. J. Gynecol. Cancer, 2002, 12, 485.

[31] Marchionni M., Fallani M.G., Fambrini M., Penna C.: "Carcinoma microinvasivo della cervice uterina: fattori di rischio e management". In: "ESGOI 2002. New technologies for Gynecologic and Obstetric Investigation". Genazzani A.R., Cela V., Artini P.G(eds.), Rome, CIC Edizioni Internazionali, 2002, 280.

[32] Makar A.P., Trope C.: "F ertility preservation in gynecologic cancer". Acta Ohstet. Gynecol. Scand., 2001, 80, 794.